China Journal of Leprosy and Skin Diseases ›› 2024, Vol. 40 ›› Issue (10): 737-738.doi: 10.12144/zgmfskin202410737

• Case Reports • Previous Articles     Next Articles

Inflammatory disseminated superficial porokeratosis treated with tofacitinib: a case report

GAO Ming1, BIAN Lu2, LEI Dongchun2, LI Min2, SHA Ke2, CAI Bingjie3, YIN Guangwen3, LI Jianguo2   

  1. 1 Department of Dermatology, Henan Provincial People's Hospital, Henan University People's Hospital, Zhengzhou 450003, China; 2 Department of Dermatology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China; 3 Department of Dermatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Online:2024-10-15 Published:2024-08-28

Abstract: A 66-year-old male presented with multiple papules and maculae for 3 years, aggravated with severe pruritus for more than 2 months. The diagnosis of inflammatory disseminated superficial porokeratosis was made according the features of manifestation and biosy. The conventional therapy was ineffective, and then, the patient was given tofacitinib 5 mg orally twice a day. After the treatment of one month, most of the the rash subsided, and the itching was relieved.

Key words: tofacitinib, inflammatory, porokeratosis, disseminated superficial